Cargando…

Preventive bilateral femoral nailing in atypical femoral fracture non responder to anabolic therapy: case report and mini-review

Currently bisphosphonates are the main antiresorptive medications used in osteoporosis. However, a prolonged use of these drugs is associated to an increased risk of atypical femoral fractures, especially in patients suffering from others predisposing clinical conditions. This report describes a cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Neri, Elisabetta, Gabriele, Livia, Bottai, Vanna, Andreani, Lorenzo, Bonicoli, Enrico, Scaglione, Michelangelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523052/
https://www.ncbi.nlm.nih.gov/pubmed/35049529
http://dx.doi.org/10.23750/abm.v92iS1.10452
Descripción
Sumario:Currently bisphosphonates are the main antiresorptive medications used in osteoporosis. However, a prolonged use of these drugs is associated to an increased risk of atypical femoral fractures, especially in patients suffering from others predisposing clinical conditions. This report describes a case of a woman presenting bilateral impending femoral fracture initially treated with bisphosphonates suspension and intramedullary nailing of right femur. Despite anabolic therapy, the patient presented progression of incomplete contralateral femoral fracture which required a second surgical treatment. The aim of this case report is to underline the need to suspect atypical femoral fracture, and, when diagnosticated, to treat them with bisphosphonates suspension, anabolic medication, and eventual prophylactic surgical procedures in non responders patients. (www.actabiomedica.it)